BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
88 hedge funds and large institutions have $212M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 9 closing their positions.
Holders
88
Holders Change
+4
Holders Change %
+4.76%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
41
Reduced
16
Closed
9
Calls
$3.59M
Puts
$1.89M
Net Calls
+$1.7M
Net Calls Change
+$3.83M
Top Buyers
1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$4.72M |
2 |
2
BlackRock
New York
|
$27.2M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$2.38M |
4 |
4
Morgan Stanley
New York
|
$4.28M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$4.28M |